TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy.

Joseph M Brandwein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.